問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
李柏賢
下載
2025-04-01 - 2027-11-30
Condition/Disease
Double-blind, placebo-controlled trial: Proportion of participants with laboratory-confirmed CDI recurrence by week 8
Test Drug
VE303
Participate Sites3Sites
Recruiting3Sites
2026-02-06 - 2032-09-25
Participate Sites7Sites
Not yet recruiting1Sites
Recruiting6Sites
2025-12-04 - 2029-12-24
Participate Sites9Sites
Recruiting7Sites
2025-12-04 - 2028-12-23
Recruiting5Sites
2026-02-12 - 2033-10-12
Recruiting8Sites
2020-03-31 - 2028-01-27
Participate Sites4Sites
Recruiting4Sites
2025-09-01 - 2032-10-06
Participate Sites5Sites
2025-09-01 - 2032-01-13
2024-08-01 - 2027-12-31
2025-08-01 - 2030-04-30
全部
